NDC product
Doxercalciferol
NDC 0955-1721 · Winthrop U.S, a business of sanofi-aventis U.S. LLC
Key facts
| Product NDC | 0955-1721 |
|---|---|
| Proprietary name | Doxercalciferol |
| Labeler | Winthrop U.S, a business of sanofi-aventis U.S. LLC |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA020862 |
| Marketing start | Apr 17, 2017 |
| Marketing end | Dec 31, 2022 |
| Listing certified through | Dec 31, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: